Artykuły w czasopismach na temat „Relapse”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Relapse”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Wudhikarn, Kitsada, Pinyo Rattanaumpawan i Margarida M. Silverman. "Characterization of Extramedullary Relapse After Allogeneic Stem Cell Transplant in Acute Myeloblastic Leukemia: Distinct Entity and Outcome". Blood 120, nr 21 (16.11.2012): 1972. http://dx.doi.org/10.1182/blood.v120.21.1972.1972.
Pełny tekst źródłaWang, Yucai, Umar Farooq, Brian K. Link, Melissa C. Larson, Rebecca L. King, Matthew J. Maurer, Cristine Allmer i in. "Late Relapses in Patients With Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy". Journal of Clinical Oncology 37, nr 21 (20.07.2019): 1819–27. http://dx.doi.org/10.1200/jco.19.00014.
Pełny tekst źródłaGanzel, Chezi, Wang Xin Victoria, Adele K. Fielding, Jacob M. Rowe, Susan M. Richards, Georgina Buck, Rajesh Chopra i in. "in Philadelphia-Chromosome-Negative Acute Lymphoblastic Leukemia, Late Relapses Are Not Uncommon, Occur Mostly in Patients at Standard Risk and Have a Relatively Favorable Outcome. Results of the International ALL Trial: MRC Ukallxii/ECOG E2993". Blood 126, nr 23 (3.12.2015): 795. http://dx.doi.org/10.1182/blood.v126.23.795.795.
Pełny tekst źródłaStolpa, Weronika, Magdalena Zapała, Bartosz Zwiernik i Agnieszka Mizia-Malarz. "Relapses Children’s Acute Lymphoblastic Leukemia, Single Center Experience". Children 9, nr 12 (30.11.2022): 1874. http://dx.doi.org/10.3390/children9121874.
Pełny tekst źródłaPlatte, Victoria, Anika Bergmann, Barbara Hildebrandt, Dagmar Wieczorek, Esther Schuler, Ulrich Germing, Jennifer Kaivers i in. "Clinical and Cytogenetic Characterization of Early and Late Relapses in Patients Allografted for Myeloid Neoplasms with a Myelodysplastic Component". Cancers 14, nr 24 (18.12.2022): 6244. http://dx.doi.org/10.3390/cancers14246244.
Pełny tekst źródłaNagane, Motoo, Nobuyoshi Sasaki, Yuki Yamagaishi, Kuniaki Saito, Keiichi Kobayashi i Hirofumi Nakatomi. "CTNI-81. REAL-WORLD TREATMENT RESULTS OF RELAPSED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA TREATED BY MEDICAL THERAPIES". Neuro-Oncology 25, Supplement_5 (1.11.2023): v96—v97. http://dx.doi.org/10.1093/neuonc/noad179.0363.
Pełny tekst źródłaBarz, Malwine J., Jana Hof, Stefanie Groeneveld-Krentz, Jui Wan Loh, Annabell Szymansky, Kathy Astrahantseff, Arend von Stackelberg i in. "Subclonal NT5C2 mutations are associated with poor outcomes after relapse of pediatric acute lymphoblastic leukemia". Blood 135, nr 12 (19.03.2020): 921–33. http://dx.doi.org/10.1182/blood.2019002499.
Pełny tekst źródłaMaxwell, Rebecca, Beate Häberle, Roland Kappler, Dietrich von Schweinitz, Mark Rassner, Julia von Frowein i Irene Schmid. "Hepatoblastoma Relapse—Findings from the German HB99 Trial and the German Liver Tumor Registry". Cancers 16, nr 4 (6.02.2024): 696. http://dx.doi.org/10.3390/cancers16040696.
Pełny tekst źródłaHill, Rebecca, Stacey Richardson, Edward Schwalbe, Debbie Hicks, Janet Lindsey, Stephen Crosier, Gholamreza Rafiee i in. "MBRS-44. TIME, PATTERN AND OUTCOME OF MEDULLOBLASTOMA RELAPSE ARE ASSOCIATED WITH TUMOUR BIOLOGY AT DIAGNOSIS AND UPFRONT THERAPY: A COHORT STUDY". Neuro-Oncology 22, Supplement_3 (1.12.2020): iii405—iii406. http://dx.doi.org/10.1093/neuonc/noaa222.553.
Pełny tekst źródłaKelaidi, C., L. Ades, S. Chevret, M. A. Sanz, A. Guerci, X. Thomas, S. de Botton i in. "Late Relapses in APL Treated with ATRA and Anthracycline Based Chemotherapy: The European APL Group Experience (APL 91 and APL 93 Trials)." Blood 106, nr 11 (16.11.2005): 890. http://dx.doi.org/10.1182/blood.v106.11.890.890.
Pełny tekst źródłaLi, Benshang, Yongjin Li, Shuhong Shen, Yingchi Zhang, Samuel Brady, Xiaotu Ma, Yu Liu i in. "Mutational Landscape and Temporal Evolution during Treatment of Relapsed Acute Lymphoblastic Leukemia". Blood 132, Supplement 1 (29.11.2018): 917. http://dx.doi.org/10.1182/blood-2018-99-119144.
Pełny tekst źródłaJohnson, Kristina K., Deirdra R. Terrell, Bernhard Lammle, Johanna Kremer Hovinga, James N. George i Sara K. Vesely. "Predicting Risk for Relapse in Patients Who Have Recovered from Thrombotic Thrombocytopenic Purpura (TTP)." Blood 108, nr 11 (16.11.2006): 91. http://dx.doi.org/10.1182/blood.v108.11.91.91.
Pełny tekst źródłaRheingold, Susan R., Lingyun Ji, Xinxin Xu, Meenakshi Devidas, Patrick A. Brown, Lia Gore, Naomi J. Winick i in. "Prognostic factors for survival after relapsed acute lymphoblastic leukemia (ALL): A Children’s Oncology Group (COG) study." Journal of Clinical Oncology 37, nr 15_suppl (20.05.2019): 10008. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.10008.
Pełny tekst źródłaHamilton, Robert J., Madhur Nayan, Lynn Anson-Cartwright, Eshetu G. Atenafu, Philippe L. Bedard, Aaron Hansen, Peter Chung i in. "Treatment of Relapse of Clinical Stage I Nonseminomatous Germ Cell Tumors on Surveillance". Journal of Clinical Oncology 37, nr 22 (1.08.2019): 1919–26. http://dx.doi.org/10.1200/jco.18.01250.
Pełny tekst źródłaRíos-Garcés, R., J. Hernández-Rodríguez, S. Prieto-González, M. C. Cid i G. Espígol-Frigolé. "AB0763 CHARACTERISTICS OF RELAPSES IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS. A SINGLE CENTRE EXPERIENCE". Annals of the Rheumatic Diseases 82, Suppl 1 (30.05.2023): 1588. http://dx.doi.org/10.1136/annrheumdis-2023-eular.2850.
Pełny tekst źródłaRajkumar, Prabu, Girish Kumar Chethrapilly Purushothaman, Manickam Ponnaiah, Devika Shanmugasundaram, Jayasree Padma, Rang Lal Meena, Selvaraj Vadivoo i Sanjay M. Mehendale. "Low risk of relapse and deformity among leprosy patients who completed multi-drug therapy regimen from 2005 to 2010: A cohort study from four districts in South India". PLOS Neglected Tropical Diseases 15, nr 11 (23.11.2021): e0009950. http://dx.doi.org/10.1371/journal.pntd.0009950.
Pełny tekst źródłaFonseca, Adriana, Cecile Faure-Conter, Matthew Murray, Jason R. Fangusaro, Stewart Goldman, Shivani Bailey, Gabriele Calaminus i in. "The role of tumor markers for relapse detection in central nervous system non-germinomatous germ cell tumors (CNS-NGGCT): A pool analysis of cooperative group clinical trials." Journal of Clinical Oncology 38, nr 15_suppl (20.05.2020): 2503. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.2503.
Pełny tekst źródłaBlum, William, Sam Penza, Sherif Farag, Belinda Avalos, Guido Marcucci, Thomas Lin, John C. Byrd, Patrick Elder i Edward A. Copelan. "Incidence of Extramedullary Relapse of Acute Myeloid Leukemia Following Transplantation with Busulfan-Based Conditioning Regimens." Blood 104, nr 11 (16.11.2004): 5123. http://dx.doi.org/10.1182/blood.v104.11.5123.5123.
Pełny tekst źródłaFlorvall, Cecilia, Peder Frederiksen, Jakob Lauritsen, Mikkel Bandak, M. Gry G. Kier, Mette S. Mortensen, Michael Kreiberg i Gedske Daugaard. "Relapse and Mortality Risk of Stage I Testicular Cancer". Journal of Insurance Medicine 47, nr 2 (1.01.2017): 114–24. http://dx.doi.org/10.17849/insm-47-02-114-124.1.
Pełny tekst źródłaHansen, M., i C. Hahn. "P.004 Autoimmune Encephalitis: Modifiable and Non-Modifiable Predictors of Relapse". Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 48, s3 (listopad 2021): S21. http://dx.doi.org/10.1017/cjn.2021.287.
Pełny tekst źródłaKumar, Prashanth, Nisha Joseph, Dhwani Almaula, Lawrence H. Boise, Jonathan L. Kaufman, Charise Gleason, Sagar Lonial i Ajay K. Nooka. "Patterns of Relapse Among Myeloma Patients Post-Autologous Stem Cell Transplant". Blood 128, nr 22 (2.12.2016): 4524. http://dx.doi.org/10.1182/blood.v128.22.4524.4524.
Pełny tekst źródłaMuirhead, Rebecca, Lisa Durrant, Katherine Hyde i Maria Hawkins. "Volumetric analysis of anal cancer relapses following radical chemoradiation." Journal of Clinical Oncology 32, nr 3_suppl (20.01.2014): 576. http://dx.doi.org/10.1200/jco.2014.32.3_suppl.576.
Pełny tekst źródłaKaspers, Gertjan, Martin Zimmermann, Dirk Reinhardt, Brenda Gibson, Rienk Tamminga, Olga Aleinikova, Hortensia Armendariz i in. "Central Nervous System (CNS) Involvement In Pediatric Relapsed Acute Myeloid Leukemia: Results and Lessons From Study Relapsed AML 2001/01". Blood 116, nr 21 (19.11.2010): 184. http://dx.doi.org/10.1182/blood.v116.21.184.184.
Pełny tekst źródłaTringale, Kathryn, Joachim Yahalom, Michael Scordo, Behroze Vachha, Lauren Schaff, Christian Grommes i Brandon Imber. "NIMG-98. IDENTIFYING PATTERNS OF FAILURE AFTER INITIAL THERAPY IN PRIMARY CNS LYMPHOMA IN A LARGE PATIENT COHORT". Neuro-Oncology 24, Supplement_7 (1.11.2022): vii187—vii188. http://dx.doi.org/10.1093/neuonc/noac209.716.
Pełny tekst źródłaCohen, Jonathon B., Madhusmita Behera, Carrie A. Thompson i Christopher R. Flowers. "Evaluating surveillance imaging for diffuse large B-cell lymphoma and Hodgkin lymphoma". Blood 129, nr 5 (2.02.2017): 561–64. http://dx.doi.org/10.1182/blood-2016-08-685073.
Pełny tekst źródłaKumar, Rahul, Maximilian Deng, Kyle Smith, Anthony P. Y. Liu, Vasilisa Rudneva, Girish Dhall, Laura Kleese i in. "PATH-54. MULTI-DIMENSIONAL MOLECULAR CHARACTERIZATION OF PATIENT-MATCHED MEDULLOBLASTOMA AT DIAGNOSIS AND RELAPSE". Neuro-Oncology 21, Supplement_6 (listopad 2019): vi155. http://dx.doi.org/10.1093/neuonc/noz175.649.
Pełny tekst źródłaOki, Yasuhiro, Dai Chihara, Yoshitoyo Kagami, Shouji Ine, Harumi Kato, Hirofumi Taji, Kazuhito Yamamoto i Yasuo Morishima. "Patterns of Relapse and Value of Follow up Procedures in Patients with Diffuse Large B Cell Lymphoma (DLBCL) Who Achieve a Complete Remission (CR)". Blood 112, nr 11 (16.11.2008): 5306. http://dx.doi.org/10.1182/blood.v112.11.5306.5306.
Pełny tekst źródłaHansen, M., i C. Hahn. "P.027 Autoimmune encephalitis: modifiable and non-modifiable predictors of relapse". Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 50, s2 (czerwiec 2023): S65. http://dx.doi.org/10.1017/cjn.2023.131.
Pełny tekst źródłaAbsi, Ahmed, Brian J. Bolwell, Ronald Sobecks, Brad Pohlman, Steve Andresen, Lisa Rybicki i Matt Kalaycio. "High Incidence of Extramedullary Relapses Following Allogeneic Bone Marrow Transplant (Allo-BMT) in Adults with Acute Lymphoblastic Leukemia." Blood 104, nr 11 (16.11.2004): 5117. http://dx.doi.org/10.1182/blood.v104.11.5117.5117.
Pełny tekst źródłaKalinina, I. I., D. A. Venyov, O. V. Goronkova, D. D. Baydildina, K. A. Voronin, M. A. Maschan i A. A. Maschan. "Treatment results of children and adolescents with relapsed AML who were initially treated according to the AML-MM-2006 protocol". Russian journal of hematology and transfusiology 68, nr 2 (17.07.2023): 152–65. http://dx.doi.org/10.35754/0234-5730-2023-68-2-152-165.
Pełny tekst źródłaShimoni, Avichai, Avital Rand, Izhar Hardan, Noga Shem-Tov, Etai Zilbershatz, Ronit Yerushalmi i Arnon Nagler. "Isolated Extra-Medullary Relapse of Acute Leukemia after Allogeneic Stem-Cell Transplantation; Different Kinetics and Better Prognosis Than Systemic Relapse." Blood 112, nr 11 (16.11.2008): 2148. http://dx.doi.org/10.1182/blood.v112.11.2148.2148.
Pełny tekst źródłaVose, Julie M., John C. Chan, Philip J. Bierman, Alejandro Arevalo, Fausto Loberiza, Kai Fu, Dennis Weisenburger, Robert G. Bociek, Martin Bast i James O. Armitage. "Relapse from Complete Remission More Than 5 Years after Therapy for Diffuse Large B-Cell Lymphoma (DLBCL): Relapse Histology Most Commonly DLBCL with a Germinal Center B-Cell (GCB) Phenotype." Blood 110, nr 11 (16.11.2007): 3430. http://dx.doi.org/10.1182/blood.v110.11.3430.3430.
Pełny tekst źródłaKÄLSCH, ANNA-ISABELLE, ELENA CSERNOK, DOMINIK MÜNCH, RAINER BIRCK, BENITO A. YARD, WOLFGANG GROSS, THORSTEN KÄLSCH i WILHELM H. SCHMITT. "Use of Highly Sensitive C-Reactive Protein for Followup of Wegener’s Granulomatosis". Journal of Rheumatology 37, nr 11 (17.08.2010): 2319–25. http://dx.doi.org/10.3899/jrheum.100302.
Pełny tekst źródłaLee, A. Y., J. M. Connors, P. Klimo, S. E. O'Reilly i R. D. Gascoyne. "Late relapse in patients with diffuse large-cell lymphoma treated with MACOP-B." Journal of Clinical Oncology 15, nr 5 (maj 1997): 1745–53. http://dx.doi.org/10.1200/jco.1997.15.5.1745.
Pełny tekst źródłaRomano, Emanuela, Michael Scordo, Stephen W. Dusza, Daniel G. Coit i Paul B. Chapman. "Site and Timing of First Relapse in Stage III Melanoma Patients: Implications for Follow-Up Guidelines". Journal of Clinical Oncology 28, nr 18 (20.06.2010): 3042–47. http://dx.doi.org/10.1200/jco.2009.26.2063.
Pełny tekst źródłaDouer, Dan, Lynette Zickl, Charles A. Schiffer, Frederick R. Appelbaum, James H. Feusner, Lois E. Shepherd, Cheryl L. Willman i in. "Late Relapses Following All-Trans Retinoic Acid for Acute Promyelocytic Leukemia Are Uncommon, Respond Well to Salvage Therapy and Occur Independently of Prognostic Factors At Diagnosis: Long-Term Follow-up of North American Intergroup Study I0129". Blood 118, nr 21 (18.11.2011): 83. http://dx.doi.org/10.1182/blood.v118.21.83.83.
Pełny tekst źródłaSchönau, V., G. Corte, S. Ott, K. Tascilar, F. Hartmann, B. Manger, B. Hellmich i in. "POS0809 CHARACTERIZATION OF RELAPSES IN PATIENTS WITH GIANT CELL ARTERITIS (GCA) PATIENTS- DATA FROM THE REAL-LIFE TREATMENT AND SAFETY (REATS)-GCA COHORT". Annals of the Rheumatic Diseases 81, Suppl 1 (23.05.2022): 694.1–694. http://dx.doi.org/10.1136/annrheumdis-2022-eular.3543.
Pełny tekst źródłaSzela, Joel, Angy Hanna i Matthew Sims. "2419. Timing of Secondary Prophylaxis Against Clostridium difficile Infection After Antibiotic Exposure". Open Forum Infectious Diseases 6, Supplement_2 (październik 2019): S835. http://dx.doi.org/10.1093/ofid/ofz360.2097.
Pełny tekst źródłaWang, Yucai, Umar Farooq, Brian K. Link, Mehrdad Hefazi, Cristine Allmer, Matthew J. Maurer, Thomas E. Witzig i in. "Relapses after Achieving EFS24 in Patients with Diffuse Large B-Cell Lymphoma in the Rituximab Era". Blood 132, Supplement 1 (29.11.2018): 454. http://dx.doi.org/10.1182/blood-2018-99-113213.
Pełny tekst źródłaKapke, Jonathan, Narendranath Epperla, Namrata Shah, Kristin Richardson, George Carrum, Parameswaran Hari, Mehdi Hamadani, Sai Ravi Pingali, Reem Karmali i Timothy S. Fenske. "Impact of Routine Surveillance Imaging on Outcomes in Patients with Classical Hodgkin Lymphoma (cHL) Undergoing Autologous Hematopoietic Cell Transplantation (auto-HCT)". Blood 126, nr 23 (3.12.2015): 3169. http://dx.doi.org/10.1182/blood.v126.23.3169.3169.
Pełny tekst źródłaOrtega, J. A., M. E. Nesbit, H. N. Sather, L. L. Robison, G. J. D'Angio i G. D. Hammond. "Long-term evaluation of a CNS prophylaxis trial--treatment comparisons and outcome after CNS relapse in childhood ALL: a report from the Childrens Cancer Study Group." Journal of Clinical Oncology 5, nr 10 (październik 1987): 1646–54. http://dx.doi.org/10.1200/jco.1987.5.10.1646.
Pełny tekst źródłaFossard, Gaelle, Emmanuelle Nicolas-Virelizier, Philippe Rey, Francois Ducray, Emmanuel Jouanneau, Pierre Faurie, Amine Belhabri i in. "Utility Of Post Therapy Brain Surveillance Imaging In The Detection Of Primary CNS Lymphoma (PCNSL) Relapse". Blood 122, nr 21 (15.11.2013): 933. http://dx.doi.org/10.1182/blood.v122.21.933.933.
Pełny tekst źródłaYamasaki, Kai, Kazuki Tanimura, Yuki Okuhiro, Kota Hira, Chika Nitani, Keiko Okada, Hiroyuki Fujisaki i in. "MBCL-22. EFFICACY OF DOUBLE-CONDITIONING REGIMEN COMPRISING THIOTEPA AND MELPHALAN FOR RELAPSED MEDULLOBLASTOMA – A SINGLE INSTITUTION EXPERIENCE". Neuro-Oncology 22, Supplement_3 (1.12.2020): iii393. http://dx.doi.org/10.1093/neuonc/noaa222.498.
Pełny tekst źródłaWeeks, J. C., B. Y. Yeap, G. P. Canellos i M. A. Shipp. "Value of follow-up procedures in patients with large-cell lymphoma who achieve a complete remission." Journal of Clinical Oncology 9, nr 7 (lipiec 1991): 1196–203. http://dx.doi.org/10.1200/jco.1991.9.7.1196.
Pełny tekst źródłaMoerdler, Scott, Arlene Naranjo, Sheena Tenney, Rochelle Bagatell, Alice L. Yu i Wendy B. London. "Patterns of relapse after immunotherapy in patients with high-risk neuroblastoma." Journal of Clinical Oncology 40, nr 16_suppl (1.06.2022): 10043. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.10043.
Pełny tekst źródłaMoerdler, Scott, Arlene Naranjo, Sheena Tenney, Rochelle Bagatell, Alice L. Yu i Wendy B. London. "Patterns of relapse after immunotherapy in patients with high-risk neuroblastoma." Journal of Clinical Oncology 40, nr 16_suppl (1.06.2022): 10043. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.10043.
Pełny tekst źródłaHerrity, Elizabeth Kathryn, Tommy Alfaro, Mariana Pinto Pereira, Igor Novitzky-Basso, Wilson Lam, Ivan Pasic, Fotios Michelis i in. "Clinical, Cytogenetic and Immunophenotypic Spectra of Post-Transplant Relapse Following Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndrome". Blood 142, Supplement 1 (28.11.2023): 2206. http://dx.doi.org/10.1182/blood-2023-187145.
Pełny tekst źródłaSchuck, Anna, Ariane Dienst, Kathrin Nachtkamp, Pia Verena Schmidt, Esther Schuler, Roland Fenk, Mustafa Kondakci i in. "Disease Characteristics, Treatment and Outcome of Patients with Myelodysplastic Syndromes Relapsing after Allogeneic Stem Cell Transplantation". Blood 126, nr 23 (3.12.2015): 3167. http://dx.doi.org/10.1182/blood.v126.23.3167.3167.
Pełny tekst źródłaEpperla, Narendranath, Namrata Shah, Kristin Richardson, Jonathan Kapke, George Carrum, Parameswaran Hari, Mehdi Hamadani, Sai Ravi Pingali, Reem Karmali i Timothy S. Fenske. "Impact of Routine Surveillance Imaging on Outcomes in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Undergoing Autologous Hematopoietic Cell Transplantation (auto-HCT)". Blood 126, nr 23 (3.12.2015): 4360. http://dx.doi.org/10.1182/blood.v126.23.4360.4360.
Pełny tekst źródłaMarinescu, Elena-Cristina, Horia Bumbea, Iuliana Iordan, Ion Dumitru, Dan Soare, Cristina Ciufu i Mihaela Gaman. "The Philadelphia Chromosome, from Negative to Positive: A Case Report of Relapsed Acute Lymphoblastic Leukemia following Allogeneic Stem Cell Transplantation". Medicina 59, nr 4 (28.03.2023): 671. http://dx.doi.org/10.3390/medicina59040671.
Pełny tekst źródła